Femasys Inc. completed a $30 million private placement to strengthen its U.S. commercial team and support growth of its fertility product portfolio, including FemaSeed®. Despite funding constraints before August, U.S. sales in Q3 2026 increased slightly to $347,039. The company is advancing its FemBloc® permanent birth control product toward FDA approval with an expanding clinical trial. While overall sales declined due to timing of international orders, Femasys is confident that new financing and commercial hires will drive revenue growth in key U.S. markets.
Femasys Inc.'s recent $30 million private placement to boost its U.S. commercial team and fertility product portfolio provides context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 14, 2026 03:21 WIB: out of 150 priced US health stocks, 81 rose and 68 fell. Notable movers include AVAH at USD 11.46 with a 1-day change of -6.37% and Pluang order activity showing 97% buy, DNA at USD 9.60 down 6.21% with 93% sell activity, and ALMS at USD 5.76 down 6.04%.
ArrowMark Financial Corp. announced a monthly cash distribution of $0.15 per share for November 2026, payable on November 30 to shareholders of record as of November 23. This distribution reflects the company's ongoing commitment to provide current i...
Liberty Defense Holdings clarified details of its credit facility and term loan with Parabilis, originally announced in 2024. The company’s subsidiary received a $1.8 million term loan and a $2.5 million revolving credit facility, both secured by sub...
Stardust Power announced a $2.8 million net loss for Q3 2026, an improvement from $4.5 million last year, driven by lower administrative costs and warrant value changes. The company is progressing its lithium refinery project in Muskogee, Oklahoma, d...
byNordic Acquisition Corporation, a special purpose acquisition company, has extended its deadline to complete a business combination by one month, moving it from November 12, 2026, to December 12, 2026. This is the fourth of up to twelve possible on...
Texas Pacific Land Corporation reported a high Return on Invested Capital (ROIC) of 30.81%, significantly surpassing its Weighted Average Cost of Capital (WACC) of 7.73%. This strong performance results in the highest ROIC-to-WACC ratio of 3.98 among...
